Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy
Clinical trial NCT02205372 · COMPLETED
Trial details
- NCT number
- NCT02205372
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-08-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.